cached image

Parents

Sign in to add mentor
Eric J. Stanbridge grad student 1981 UC Irvine (Chemistry Tree)
 (Cell surface alterations associated with transformation and tumorgenicity in human cells.)
Geoffrey M. Cooper post-doc 1982 Harvard Medical School (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382
Ozkan-Dagliyan I, Diehl JN, George SD, et al. (2020) Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers. Cell Reports. 31: 107764
Bryant KL, Stalnecker CA, Zeitouni D, et al. (2020) Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nature Medicine
Zhang H, Schaefer A, Wang Y, et al. (2019) Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer. Cancer Discovery
Hobbs GA, Baker NM, Miermont AM, et al. (2019) Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. Cancer Discovery
Blake DR, Vaseva AV, Hodge RG, et al. (2019) Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer. Science Signaling. 12
Bryant KL, Stalnecker CA, Zeitouni D, et al. (2019) Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nature Medicine
Vaseva AV, Blake DR, Gilbert TSK, et al. (2018) KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism. Cancer Cell. 34: 807-822.e7
Waters AM, Ozkan-Dagliyan I, Vaseva AV, et al. (2017) Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies. Science Signaling. 10
Stratford JK, Yan F, Hill RA, et al. (2017) Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability. Plos One. 12: e0174863
See more...